Show simple item record

IMPACT OF ADDING MIFAMURTIDE TO A NON-METHOTREXATE THREE-DRUG CHEMOTHERAPY REGIMEN

dc.contributor.authorBuyukkapu, Sema Bay
dc.contributor.authorSalduz, Ahmet
dc.contributor.authorYildirim, Ulku Miray
dc.contributor.authorKebudi, Rejin
dc.date.accessioned2023-02-21T08:47:24Z
dc.date.available2023-02-21T08:47:24Z
dc.identifier.citationKebudi R., Buyukkapu S. B., Yildirim U. M., Salduz A., "IMPACT OF ADDING MIFAMURTIDE TO A NON-METHOTREXATE THREE-DRUG CHEMOTHERAPY REGIMEN", PEDIATRIC BLOOD & CANCER, cilt.69, 2022
dc.identifier.issn1545-5009
dc.identifier.othervv_1032021
dc.identifier.otherav_21dab40c-1f50-4979-80f8-eb4c656c6fd8
dc.identifier.urihttp://hdl.handle.net/20.500.12627/186963
dc.language.isoeng
dc.subjectTıp
dc.subjectDahili Tıp Bilimleri
dc.subjectÇocuk Sağlığı ve Hastalıkları
dc.subjectİç Hastalıkları
dc.subjectHematoloji
dc.subjectOnkoloji
dc.subjectSağlık Bilimleri
dc.subjectPediatri
dc.subjectPediatri, Perinatoloji ve Çocuk Sağlığı
dc.subjectHEMATOLOJİ
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.subjectPEDİATRİ
dc.titleIMPACT OF ADDING MIFAMURTIDE TO A NON-METHOTREXATE THREE-DRUG CHEMOTHERAPY REGIMEN
dc.typeMakale
dc.relation.journalPEDIATRIC BLOOD & CANCER
dc.contributor.departmentİstanbul Üniversitesi , Onkoloji Enstitüsü , Klinik Onkoloji Ana Bilim Dalı
dc.identifier.volume69
dc.contributor.firstauthorID4071147


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record